brigantinib
Interviews and expert commentary tagged “brigantinib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
ALK—Targeted Lung Cancer Drugs Benefited Real World Patients
MUNICH— Anaplastic lymphoma kinase (ALK) inhibitors are as effective in “real world” clinical use for treating patients with non-small cell lung cancer (NSCLC) who test positive for ALK ge
7 November 2018
9 minutes